Results 191 to 200 of about 4,703,837 (246)
Some of the next articles are maybe not open access.
Aryl-2-piperidylcarbinols: Potential Cardiovascular Agents
Journal of Pharmaceutical Sciences, 1971Abstract The syntheses of some substituted aryl-2-piperidylcarbinols are described. Weak α- and/or β-agonist and/or antagonist activity was observed in preliminary experimental studies in animals.
J, Sam, D N, Vacik, M N, Aboul-Enein
openaire +2 more sources
Cardiovascular toxicity of molecularly targeted agents
European Journal of Cancer, 2009Over the last decade, molecularly targeted drugs have become established in oncology therapeutics and clinical research. While initially marketed as “cancer specific” agents with superior toxicity profiles to conventional anti-proliferative and DNA-damaging chemotherapy, it has become increasingly apparent that these drugs have numerous serious “on ...
Elizabeth L, Strevel, Lillian L, Siu
openaire +2 more sources
Urokinase-a Very Popular Cardiovascular Agent
Recent Patents on Cardiovascular Drug Discovery, 2008Urokinase (UK) [EC 3.4.99.26] is a serine protease that activates plasminogen to plasmin, which in turn degrades fibrin clots. Hence, UK finds its value as an important anti-thromboembolic drug. Plasmin has diverse physiological roles apart from its fibrinolytic role in the regulation of blood clotting.
Adinarayana, Kunamneni +4 more
openaire +2 more sources
Novel Antiplatelet Agents in Cardiovascular Medicine
Current Treatment Options in Cardiovascular Medicine, 2015Dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker, particularly clopidogrel, has been the standard of therapy for secondary prevention in patients with acute coronary syndromes and patients treated with percutaneous coronary intervention.
Rahil, Rafeedheen +4 more
openaire +2 more sources
Chapter 7. Cardiovascular Agents
1975Publisher Summary This chapter discusses potentially important non-diuretic hypotensive, antiarrythmic and antianginal agents. The oldest known hypotensives is sodium nitroprusside. It is indicated for rapid reduction of blood pressure in hypertensive crisis and is given only as an intravenous infusion because its effect is evanescent.
openaire +1 more source
Cardiovascular Effects of Intravenous Anesthetic Agents
1985The most commonly used anesthetic agents of this kind are the barbiturates. The duration of action of these agents is tied to their fat solubility. Since the thiobarbiturates are more fat soluble (classified as ultra-short acting), they provide a surgical plane of anesthesia for less time than the short acting agents such as pentobarbital sodium.
openaire +1 more source
Therapeutic potential of chalcones as cardiovascular agents.
Life Science, 2016Debarshi Kar Mahapatra, S. Bharti
semanticscholar +1 more source
[Pregnancy and cardiovascular agents].
Annales de cardiologie et d'angeiologie, 1993Any treatment used in pregnant women must take into account the effects of the substance in question of the fetus and the particular sensitivity of the latter during the first three months of development. The majority of drugs used in cardiology can be prescribed during pregnancy: digitalis preparations, furosemide, certain beta-blockers, verapamil ...
openaire +1 more source
Intravitreal anti-VEGF agents and cardiovascular risk
Internal and Emergency Medicine, 2019M. Porta, E. Striglia
semanticscholar +1 more source